Westlake Village BioPartners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease.
AI & Machine LearningBiotechDeep TechDigital HealthSouth San Francisco, US
Nancy Stagliano(CEO)in
Co-investorsHBM Healthcare InvestmentsHBM PartnersKleiner PerkinsSoftBank GroupSoftBank Vision FundACORN BIOVENTURES+2 more
Uprise builds AI-based financial tools aimed at small business owners, addressing their combined business and personal financial needs.
AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US
Nanthakumar Muthusamy(Founder)inChris Goodmacher(Co-Founder)inJessica Chen Riolfi(Co-Founder & CEO)in
Co-investorsBlank VenturesContraryGraham Walker VentureOxonian VenturesSerac VenturesDash Fund+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










